Dr John R Jenkins, DO | |
222 Medical Cir, Morehead, KY 40351-1179 | |
(606) 783-6500 | |
(606) 783-6878 |
Full Name | Dr John R Jenkins |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 12 Years |
Location | 222 Medical Cir, Morehead, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790030013 | NPI | - | NPPES |
7100667890 | Medicaid | KY | |
1790030013 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 0102203664 (Virginia) | Secondary |
207R00000X | Internal Medicine | 04719 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Claire Medical Center Home Health | Morehead, KY | Home health agency |
St Claire Regional Medical Center | Morehead, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St. Claire Medical Center Inc | 4486559085 | 120 |
News Archive
News outlets offer a variety of stories about Medicare, including details of a new bidding process for medical equipment and the scheduled cut in physician reimbursement.
Patients with advanced prostate cancer in Scotland will not get access to a new drug which can extend their lives by more than three months. Prostate cancer is the most common cancer to affect men and the second most common cause of death.
To withstand external mechanical stress and handle trafficking of various substances, a cell needs to adjust its surrounding membrane.
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg (base), 50 mg (base) and 100 mg (base). This product is manufactured in Mylan's Morgantown, W.Va. facility.
It only takes a few bad sunburns or trips to the tanning bed to put someone at risk for melanoma. Skin cancer is the most common type of cancer in the United States and when left untreated, melanoma is the most dangerous and aggressive form. It accounts for more than 9,000 of the 12,000-plus skin cancer deaths each year. In observance of May's Melanoma and Skin Cancer Awareness Month Seattle Cancer Care Alliance (SCCA) is focusing on helping teens keep their skin safe this spring with a new infographic.
› Verified 4 days ago
Entity Name | St. Claire Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821168535 PECOS PAC ID: 4486559085 Enrollment ID: O20031205000579 |
News Archive
News outlets offer a variety of stories about Medicare, including details of a new bidding process for medical equipment and the scheduled cut in physician reimbursement.
Patients with advanced prostate cancer in Scotland will not get access to a new drug which can extend their lives by more than three months. Prostate cancer is the most common cancer to affect men and the second most common cause of death.
To withstand external mechanical stress and handle trafficking of various substances, a cell needs to adjust its surrounding membrane.
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg (base), 50 mg (base) and 100 mg (base). This product is manufactured in Mylan's Morgantown, W.Va. facility.
It only takes a few bad sunburns or trips to the tanning bed to put someone at risk for melanoma. Skin cancer is the most common type of cancer in the United States and when left untreated, melanoma is the most dangerous and aggressive form. It accounts for more than 9,000 of the 12,000-plus skin cancer deaths each year. In observance of May's Melanoma and Skin Cancer Awareness Month Seattle Cancer Care Alliance (SCCA) is focusing on helping teens keep their skin safe this spring with a new infographic.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr John R Jenkins, DO 222 Medical Cir, Morehead, KY 40351-1179 Ph: (606) 783-6500 | Dr John R Jenkins, DO 222 Medical Cir, Morehead, KY 40351-1179 Ph: (606) 783-6500 |
News Archive
News outlets offer a variety of stories about Medicare, including details of a new bidding process for medical equipment and the scheduled cut in physician reimbursement.
Patients with advanced prostate cancer in Scotland will not get access to a new drug which can extend their lives by more than three months. Prostate cancer is the most common cancer to affect men and the second most common cause of death.
To withstand external mechanical stress and handle trafficking of various substances, a cell needs to adjust its surrounding membrane.
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg (base), 50 mg (base) and 100 mg (base). This product is manufactured in Mylan's Morgantown, W.Va. facility.
It only takes a few bad sunburns or trips to the tanning bed to put someone at risk for melanoma. Skin cancer is the most common type of cancer in the United States and when left untreated, melanoma is the most dangerous and aggressive form. It accounts for more than 9,000 of the 12,000-plus skin cancer deaths each year. In observance of May's Melanoma and Skin Cancer Awareness Month Seattle Cancer Care Alliance (SCCA) is focusing on helping teens keep their skin safe this spring with a new infographic.
› Verified 4 days ago
Albert J Smith Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 | |
Dr. Johannie Keith Uy, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6471 | |
Indu Shivaram, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 245 Flemingsburg Rd, Morehead, KY 40351 Phone: 606-780-5500 Fax: 606-780-5512 | |
Ravneet Thind, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 245 Flemingsburg Rd, Morehead, KY 40351 Phone: 606-780-5500 | |
Dr. Mansha U Kahloon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 245 Flemingsburg Rd, Morehead, KY 40351 Phone: 606-780-5500 Fax: 606-780-5512 | |
Shea Poynter Lambirth, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 | |
Christie Dawn Conn, PA-C Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Ky 801 North, Morehead, KY 40351 Phone: 606-548-5550 Fax: 833-471-4492 |